nodes	percent_of_prediction	percent_of_DWPC	metapath
Alprazolam—Altered state of consciousness—Temozolomide—malignant glioma	0.0158	0.0265	CcSEcCtD
Alprazolam—Cerebration impaired—Temozolomide—malignant glioma	0.0124	0.0208	CcSEcCtD
Alprazolam—Apathy—Temozolomide—malignant glioma	0.0102	0.0171	CcSEcCtD
Alprazolam—Flat affect—Temozolomide—malignant glioma	0.0101	0.017	CcSEcCtD
Alprazolam—Stupor—Carmustine—malignant glioma	0.0101	0.017	CcSEcCtD
Alprazolam—Memory impairment—Temozolomide—malignant glioma	0.00931	0.0156	CcSEcCtD
Alprazolam—Hyperaesthesia—Temozolomide—malignant glioma	0.00931	0.0156	CcSEcCtD
Alprazolam—Rigors—Temozolomide—malignant glioma	0.00895	0.015	CcSEcCtD
Alprazolam—Disturbance in attention—Temozolomide—malignant glioma	0.00844	0.0141	CcSEcCtD
Alprazolam—Coordination abnormal—Carmustine—malignant glioma	0.0077	0.0129	CcSEcCtD
Alprazolam—Coordination abnormal—Temozolomide—malignant glioma	0.00744	0.0125	CcSEcCtD
Alprazolam—Depressed level of consciousness—Carmustine—malignant glioma	0.0073	0.0122	CcSEcCtD
Alprazolam—Urinary incontinence—Carmustine—malignant glioma	0.0073	0.0122	CcSEcCtD
Alprazolam—GABRA5—telencephalon—malignant glioma	0.00709	0.0486	CbGeAlD
Alprazolam—Depressed level of consciousness—Temozolomide—malignant glioma	0.00706	0.0118	CcSEcCtD
Alprazolam—Urinary incontinence—Temozolomide—malignant glioma	0.00706	0.0118	CcSEcCtD
Alprazolam—Gynaecomastia—Carmustine—malignant glioma	0.00677	0.0113	CcSEcCtD
Alprazolam—Mental disability—Carmustine—malignant glioma	0.00656	0.011	CcSEcCtD
Alprazolam—Mental disability—Temozolomide—malignant glioma	0.00634	0.0106	CcSEcCtD
Alprazolam—Ear pain—Temozolomide—malignant glioma	0.00622	0.0104	CcSEcCtD
Alprazolam—GABRB2—brainstem—malignant glioma	0.00607	0.0416	CbGeAlD
Alprazolam—Hepatic failure—Temozolomide—malignant glioma	0.0059	0.00989	CcSEcCtD
Alprazolam—Amnesia—Carmustine—malignant glioma	0.00584	0.00979	CcSEcCtD
Alprazolam—Nasal congestion—Temozolomide—malignant glioma	0.00582	0.00976	CcSEcCtD
Alprazolam—Hot flush—Temozolomide—malignant glioma	0.00567	0.0095	CcSEcCtD
Alprazolam—Amnesia—Temozolomide—malignant glioma	0.00565	0.00946	CcSEcCtD
Alprazolam—Menopausal symptoms—Temozolomide—malignant glioma	0.00562	0.00942	CcSEcCtD
Alprazolam—Thirst—Temozolomide—malignant glioma	0.00557	0.00934	CcSEcCtD
Alprazolam—GABRA2—brainstem—malignant glioma	0.00554	0.038	CbGeAlD
Alprazolam—Diplopia—Carmustine—malignant glioma	0.00549	0.0092	CcSEcCtD
Alprazolam—GABRB2—telencephalon—malignant glioma	0.00538	0.0369	CbGeAlD
Alprazolam—GABRG2—telencephalon—malignant glioma	0.00538	0.0369	CbGeAlD
Alprazolam—GABRA1—brainstem—malignant glioma	0.00536	0.0367	CbGeAlD
Alprazolam—Diplopia—Temozolomide—malignant glioma	0.0053	0.00889	CcSEcCtD
Alprazolam—Affect lability—Temozolomide—malignant glioma	0.00522	0.00875	CcSEcCtD
Alprazolam—Ataxia—Carmustine—malignant glioma	0.00516	0.00865	CcSEcCtD
Alprazolam—Liver function test abnormal—Carmustine—malignant glioma	0.00507	0.00849	CcSEcCtD
Alprazolam—Mood swings—Temozolomide—malignant glioma	0.00502	0.00842	CcSEcCtD
Alprazolam—Ataxia—Temozolomide—malignant glioma	0.00499	0.00836	CcSEcCtD
Alprazolam—GABRA2—telencephalon—malignant glioma	0.00492	0.0337	CbGeAlD
Alprazolam—Muscular weakness—Carmustine—malignant glioma	0.00484	0.00811	CcSEcCtD
Alprazolam—Breast disorder—Temozolomide—malignant glioma	0.00479	0.00803	CcSEcCtD
Alprazolam—GABRA1—telencephalon—malignant glioma	0.00475	0.0326	CbGeAlD
Alprazolam—Dysphagia—Carmustine—malignant glioma	0.00474	0.00795	CcSEcCtD
Alprazolam—Muscular weakness—Temozolomide—malignant glioma	0.00468	0.00784	CcSEcCtD
Alprazolam—Dysphagia—Temozolomide—malignant glioma	0.00458	0.00768	CcSEcCtD
Alprazolam—Sweating increased—Temozolomide—malignant glioma	0.00447	0.00748	CcSEcCtD
Alprazolam—Dysuria—Temozolomide—malignant glioma	0.00429	0.00718	CcSEcCtD
Alprazolam—Upper respiratory tract infection—Temozolomide—malignant glioma	0.00426	0.00714	CcSEcCtD
Alprazolam—Pollakiuria—Temozolomide—malignant glioma	0.00424	0.0071	CcSEcCtD
Alprazolam—GABRB2—medulla oblongata—malignant glioma	0.00423	0.029	CbGeAlD
Alprazolam—GABRG2—medulla oblongata—malignant glioma	0.00423	0.029	CbGeAlD
Alprazolam—Depression—Carmustine—malignant glioma	0.00422	0.00707	CcSEcCtD
Alprazolam—Photosensitivity reaction—Temozolomide—malignant glioma	0.00418	0.00701	CcSEcCtD
Alprazolam—Weight increased—Temozolomide—malignant glioma	0.00417	0.00699	CcSEcCtD
Alprazolam—Weight decreased—Temozolomide—malignant glioma	0.00415	0.00695	CcSEcCtD
Alprazolam—GABRB3—telencephalon—malignant glioma	0.00413	0.0283	CbGeAlD
Alprazolam—Infestation NOS—Temozolomide—malignant glioma	0.00409	0.00685	CcSEcCtD
Alprazolam—Infestation—Temozolomide—malignant glioma	0.00409	0.00685	CcSEcCtD
Alprazolam—Depression—Temozolomide—malignant glioma	0.00408	0.00683	CcSEcCtD
Alprazolam—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.00405	0.00679	CcSEcCtD
Alprazolam—GABRA5—central nervous system—malignant glioma	0.00403	0.0276	CbGeAlD
Alprazolam—GABRB2—midbrain—malignant glioma	0.00387	0.0265	CbGeAlD
Alprazolam—GABRG2—midbrain—malignant glioma	0.00387	0.0265	CbGeAlD
Alprazolam—Hepatobiliary disease—Temozolomide—malignant glioma	0.00387	0.00648	CcSEcCtD
Alprazolam—Hallucination—Carmustine—malignant glioma	0.00378	0.00633	CcSEcCtD
Alprazolam—Hypoaesthesia—Carmustine—malignant glioma	0.00378	0.00633	CcSEcCtD
Alprazolam—GABRB2—spinal cord—malignant glioma	0.00377	0.0259	CbGeAlD
Alprazolam—GABRG2—spinal cord—malignant glioma	0.00377	0.0259	CbGeAlD
Alprazolam—GABRA3—central nervous system—malignant glioma	0.00375	0.0257	CbGeAlD
Alprazolam—Oedema peripheral—Carmustine—malignant glioma	0.00374	0.00627	CcSEcCtD
Alprazolam—GABRA1—medulla oblongata—malignant glioma	0.00374	0.0256	CbGeAlD
Alprazolam—Connective tissue disorder—Carmustine—malignant glioma	0.00373	0.00625	CcSEcCtD
Alprazolam—Hepatitis—Temozolomide—malignant glioma	0.00367	0.00615	CcSEcCtD
Alprazolam—Hallucination—Temozolomide—malignant glioma	0.00365	0.00612	CcSEcCtD
Alprazolam—Hypoaesthesia—Temozolomide—malignant glioma	0.00365	0.00612	CcSEcCtD
Alprazolam—Urinary tract disorder—Temozolomide—malignant glioma	0.00362	0.00607	CcSEcCtD
Alprazolam—Oedema peripheral—Temozolomide—malignant glioma	0.00361	0.00606	CcSEcCtD
Alprazolam—Connective tissue disorder—Temozolomide—malignant glioma	0.00361	0.00604	CcSEcCtD
Alprazolam—Urethral disorder—Temozolomide—malignant glioma	0.0036	0.00603	CcSEcCtD
Alprazolam—Clobazam—CYP2C18—malignant glioma	0.00357	0.193	CrCbGaD
Alprazolam—Eye disorder—Carmustine—malignant glioma	0.00355	0.00595	CcSEcCtD
Alprazolam—Erythema multiforme—Temozolomide—malignant glioma	0.00347	0.00581	CcSEcCtD
Alprazolam—Eye disorder—Temozolomide—malignant glioma	0.00343	0.00575	CcSEcCtD
Alprazolam—Tinnitus—Temozolomide—malignant glioma	0.00342	0.00573	CcSEcCtD
Alprazolam—GABRA1—midbrain—malignant glioma	0.00341	0.0234	CbGeAlD
Alprazolam—Cardiac disorder—Temozolomide—malignant glioma	0.00341	0.00571	CcSEcCtD
Alprazolam—GABRA1—spinal cord—malignant glioma	0.00333	0.0228	CbGeAlD
Alprazolam—Angiopathy—Temozolomide—malignant glioma	0.00333	0.00558	CcSEcCtD
Alprazolam—Mental disorder—Carmustine—malignant glioma	0.00333	0.00557	CcSEcCtD
Alprazolam—Mediastinal disorder—Temozolomide—malignant glioma	0.00331	0.00554	CcSEcCtD
Alprazolam—Malnutrition—Carmustine—malignant glioma	0.00331	0.00554	CcSEcCtD
Alprazolam—Chills—Temozolomide—malignant glioma	0.00329	0.00552	CcSEcCtD
Alprazolam—GABRB3—medulla oblongata—malignant glioma	0.00325	0.0223	CbGeAlD
Alprazolam—Mental disorder—Temozolomide—malignant glioma	0.00321	0.00539	CcSEcCtD
Alprazolam—GABRA5—brain—malignant glioma	0.0032	0.0219	CbGeAlD
Alprazolam—Back pain—Carmustine—malignant glioma	0.0032	0.00536	CcSEcCtD
Alprazolam—Malnutrition—Temozolomide—malignant glioma	0.00319	0.00535	CcSEcCtD
Alprazolam—Vision blurred—Carmustine—malignant glioma	0.00312	0.00522	CcSEcCtD
Alprazolam—Tremor—Carmustine—malignant glioma	0.0031	0.00519	CcSEcCtD
Alprazolam—Back pain—Temozolomide—malignant glioma	0.00309	0.00518	CcSEcCtD
Alprazolam—GABRB2—central nervous system—malignant glioma	0.00306	0.021	CbGeAlD
Alprazolam—GABRG2—central nervous system—malignant glioma	0.00306	0.021	CbGeAlD
Alprazolam—Agitation—Carmustine—malignant glioma	0.00304	0.00509	CcSEcCtD
Alprazolam—Vision blurred—Temozolomide—malignant glioma	0.00301	0.00504	CcSEcCtD
Alprazolam—Tremor—Temozolomide—malignant glioma	0.00299	0.00502	CcSEcCtD
Alprazolam—GABRG2—cerebellum—malignant glioma	0.00299	0.0205	CbGeAlD
Alprazolam—GABRB2—cerebellum—malignant glioma	0.00299	0.0205	CbGeAlD
Alprazolam—GABRA3—brain—malignant glioma	0.00298	0.0204	CbGeAlD
Alprazolam—GABRB3—midbrain—malignant glioma	0.00297	0.0204	CbGeAlD
Alprazolam—Ill-defined disorder—Temozolomide—malignant glioma	0.00296	0.00497	CcSEcCtD
Alprazolam—Agitation—Temozolomide—malignant glioma	0.00294	0.00492	CcSEcCtD
Alprazolam—Angioedema—Temozolomide—malignant glioma	0.00292	0.00489	CcSEcCtD
Alprazolam—GABRB3—spinal cord—malignant glioma	0.0029	0.0199	CbGeAlD
Alprazolam—Malaise—Temozolomide—malignant glioma	0.00288	0.00483	CcSEcCtD
Alprazolam—Vertigo—Temozolomide—malignant glioma	0.00287	0.00481	CcSEcCtD
Alprazolam—Convulsion—Carmustine—malignant glioma	0.00286	0.0048	CcSEcCtD
Alprazolam—Palpitations—Temozolomide—malignant glioma	0.00282	0.00473	CcSEcCtD
Alprazolam—Myalgia—Carmustine—malignant glioma	0.00281	0.00472	CcSEcCtD
Alprazolam—Chest pain—Carmustine—malignant glioma	0.00281	0.00472	CcSEcCtD
Alprazolam—Anxiety—Carmustine—malignant glioma	0.0028	0.0047	CcSEcCtD
Alprazolam—GABRA2—central nervous system—malignant glioma	0.0028	0.0192	CbGeAlD
Alprazolam—Convulsion—Temozolomide—malignant glioma	0.00277	0.00464	CcSEcCtD
Alprazolam—GABRA2—cerebellum—malignant glioma	0.00273	0.0187	CbGeAlD
Alprazolam—Confusional state—Carmustine—malignant glioma	0.00272	0.00456	CcSEcCtD
Alprazolam—Arthralgia—Temozolomide—malignant glioma	0.00272	0.00456	CcSEcCtD
Alprazolam—Myalgia—Temozolomide—malignant glioma	0.00272	0.00456	CcSEcCtD
Alprazolam—Anxiety—Temozolomide—malignant glioma	0.00271	0.00454	CcSEcCtD
Alprazolam—GABRA1—central nervous system—malignant glioma	0.0027	0.0185	CbGeAlD
Alprazolam—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.0027	0.00453	CcSEcCtD
Alprazolam—Oedema—Carmustine—malignant glioma	0.0027	0.00452	CcSEcCtD
Alprazolam—Discomfort—Temozolomide—malignant glioma	0.00269	0.0045	CcSEcCtD
Alprazolam—Infection—Carmustine—malignant glioma	0.00268	0.00449	CcSEcCtD
Alprazolam—Dry mouth—Temozolomide—malignant glioma	0.00266	0.00446	CcSEcCtD
Alprazolam—Clobazam—CYP2B6—malignant glioma	0.00265	0.143	CrCbGaD
Alprazolam—GABRA1—cerebellum—malignant glioma	0.00264	0.0181	CbGeAlD
Alprazolam—Tachycardia—Carmustine—malignant glioma	0.00263	0.00441	CcSEcCtD
Alprazolam—Confusional state—Temozolomide—malignant glioma	0.00263	0.00441	CcSEcCtD
Alprazolam—Oedema—Temozolomide—malignant glioma	0.00261	0.00437	CcSEcCtD
Alprazolam—Infection—Temozolomide—malignant glioma	0.00259	0.00434	CcSEcCtD
Alprazolam—Anorexia—Carmustine—malignant glioma	0.00257	0.00431	CcSEcCtD
Alprazolam—Nervous system disorder—Temozolomide—malignant glioma	0.00256	0.00428	CcSEcCtD
Alprazolam—Skin disorder—Temozolomide—malignant glioma	0.00253	0.00424	CcSEcCtD
Alprazolam—Hypotension—Carmustine—malignant glioma	0.00252	0.00422	CcSEcCtD
Alprazolam—Hyperhidrosis—Temozolomide—malignant glioma	0.00252	0.00422	CcSEcCtD
Alprazolam—Anorexia—Temozolomide—malignant glioma	0.00249	0.00416	CcSEcCtD
Alprazolam—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00246	0.00412	CcSEcCtD
Alprazolam—Insomnia—Carmustine—malignant glioma	0.00244	0.00409	CcSEcCtD
Alprazolam—GABRB2—brain—malignant glioma	0.00243	0.0167	CbGeAlD
Alprazolam—GABRG2—brain—malignant glioma	0.00243	0.0167	CbGeAlD
Alprazolam—Flunitrazepam—CYP2B6—malignant glioma	0.00243	0.131	CrCbGaD
Alprazolam—Paraesthesia—Carmustine—malignant glioma	0.00242	0.00406	CcSEcCtD
Alprazolam—Dyspnoea—Carmustine—malignant glioma	0.00241	0.00403	CcSEcCtD
Alprazolam—Somnolence—Carmustine—malignant glioma	0.0024	0.00402	CcSEcCtD
Alprazolam—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00238	0.00398	CcSEcCtD
Alprazolam—Insomnia—Temozolomide—malignant glioma	0.00236	0.00395	CcSEcCtD
Alprazolam—GABRB3—central nervous system—malignant glioma	0.00235	0.0161	CbGeAlD
Alprazolam—Decreased appetite—Carmustine—malignant glioma	0.00235	0.00393	CcSEcCtD
Alprazolam—Paraesthesia—Temozolomide—malignant glioma	0.00234	0.00392	CcSEcCtD
Alprazolam—Gastrointestinal disorder—Carmustine—malignant glioma	0.00233	0.0039	CcSEcCtD
Alprazolam—Dyspnoea—Temozolomide—malignant glioma	0.00232	0.00389	CcSEcCtD
Alprazolam—Somnolence—Temozolomide—malignant glioma	0.00232	0.00388	CcSEcCtD
Alprazolam—Constipation—Carmustine—malignant glioma	0.00231	0.00387	CcSEcCtD
Alprazolam—GABRB3—cerebellum—malignant glioma	0.0023	0.0157	CbGeAlD
Alprazolam—Dyspepsia—Temozolomide—malignant glioma	0.00229	0.00385	CcSEcCtD
Alprazolam—Decreased appetite—Temozolomide—malignant glioma	0.00227	0.0038	CcSEcCtD
Alprazolam—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00225	0.00377	CcSEcCtD
Alprazolam—Fatigue—Temozolomide—malignant glioma	0.00225	0.00377	CcSEcCtD
Alprazolam—Constipation—Temozolomide—malignant glioma	0.00223	0.00374	CcSEcCtD
Alprazolam—Feeling abnormal—Carmustine—malignant glioma	0.00222	0.00373	CcSEcCtD
Alprazolam—GABRA2—brain—malignant glioma	0.00222	0.0152	CbGeAlD
Alprazolam—Gastrointestinal pain—Carmustine—malignant glioma	0.00221	0.0037	CcSEcCtD
Alprazolam—Feeling abnormal—Temozolomide—malignant glioma	0.00215	0.0036	CcSEcCtD
Alprazolam—GABRA1—brain—malignant glioma	0.00215	0.0147	CbGeAlD
Alprazolam—Abdominal pain—Carmustine—malignant glioma	0.00213	0.00357	CcSEcCtD
Alprazolam—Body temperature increased—Carmustine—malignant glioma	0.00213	0.00357	CcSEcCtD
Alprazolam—Gastrointestinal pain—Temozolomide—malignant glioma	0.00213	0.00357	CcSEcCtD
Alprazolam—Diazepam—CYP2C18—malignant glioma	0.00208	0.113	CrCbGaD
Alprazolam—Urticaria—Temozolomide—malignant glioma	0.00207	0.00347	CcSEcCtD
Alprazolam—Abdominal pain—Temozolomide—malignant glioma	0.00206	0.00345	CcSEcCtD
Alprazolam—Body temperature increased—Temozolomide—malignant glioma	0.00206	0.00345	CcSEcCtD
Alprazolam—Hypersensitivity—Carmustine—malignant glioma	0.00199	0.00333	CcSEcCtD
Alprazolam—Asthenia—Carmustine—malignant glioma	0.00194	0.00324	CcSEcCtD
Alprazolam—Hypersensitivity—Temozolomide—malignant glioma	0.00192	0.00322	CcSEcCtD
Alprazolam—Asthenia—Temozolomide—malignant glioma	0.00187	0.00313	CcSEcCtD
Alprazolam—GABRB3—brain—malignant glioma	0.00187	0.0128	CbGeAlD
Alprazolam—Temazepam—CYP2B6—malignant glioma	0.00186	0.101	CrCbGaD
Alprazolam—Diarrhoea—Carmustine—malignant glioma	0.00185	0.00309	CcSEcCtD
Alprazolam—Pruritus—Temozolomide—malignant glioma	0.00184	0.00309	CcSEcCtD
Alprazolam—Midazolam—CYP2B6—malignant glioma	0.00181	0.0975	CrCbGaD
Alprazolam—Dizziness—Carmustine—malignant glioma	0.00178	0.00299	CcSEcCtD
Alprazolam—Diarrhoea—Temozolomide—malignant glioma	0.00178	0.00299	CcSEcCtD
Alprazolam—Dizziness—Temozolomide—malignant glioma	0.00172	0.00289	CcSEcCtD
Alprazolam—Vomiting—Carmustine—malignant glioma	0.00172	0.00287	CcSEcCtD
Alprazolam—Rash—Carmustine—malignant glioma	0.0017	0.00285	CcSEcCtD
Alprazolam—Dermatitis—Carmustine—malignant glioma	0.0017	0.00285	CcSEcCtD
Alprazolam—Headache—Carmustine—malignant glioma	0.00169	0.00283	CcSEcCtD
Alprazolam—Vomiting—Temozolomide—malignant glioma	0.00166	0.00278	CcSEcCtD
Alprazolam—Rash—Temozolomide—malignant glioma	0.00164	0.00275	CcSEcCtD
Alprazolam—Dermatitis—Temozolomide—malignant glioma	0.00164	0.00275	CcSEcCtD
Alprazolam—Headache—Temozolomide—malignant glioma	0.00163	0.00274	CcSEcCtD
Alprazolam—Nausea—Carmustine—malignant glioma	0.0016	0.00269	CcSEcCtD
Alprazolam—Loxapine—SLC6A3—malignant glioma	0.00155	0.0837	CrCbGaD
Alprazolam—Nausea—Temozolomide—malignant glioma	0.00155	0.00259	CcSEcCtD
Alprazolam—Diazepam—CYP2B6—malignant glioma	0.00155	0.0836	CrCbGaD
Alprazolam—CYP3A4—central nervous system—malignant glioma	0.0012	0.00825	CbGeAlD
Alprazolam—Diazepam—PTGS1—malignant glioma	0.00102	0.055	CrCbGaD
Alprazolam—GABRB3—Neuronal System—SLC6A3—malignant glioma	0.000427	0.00179	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—RTEL1—malignant glioma	0.000425	0.00178	CbGpPWpGaD
Alprazolam—CYP3A7—Biological oxidations—GSTP1—malignant glioma	0.00042	0.00176	CbGpPWpGaD
Alprazolam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—malignant glioma	0.00042	0.00176	CbGpPWpGaD
Alprazolam—GABRG2—Neuronal System—SLC6A3—malignant glioma	0.00042	0.00176	CbGpPWpGaD
Alprazolam—GABRB3—BDNF signaling pathway—APC—malignant glioma	0.000419	0.00175	CbGpPWpGaD
Alprazolam—CYP3A7—Metapathway biotransformation—GSTP1—malignant glioma	0.000415	0.00174	CbGpPWpGaD
Alprazolam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—malignant glioma	0.000412	0.00173	CbGpPWpGaD
Alprazolam—GABRB3—BDNF signaling pathway—PTPN11—malignant glioma	0.000412	0.00172	CbGpPWpGaD
Alprazolam—CYP3A5—Biological oxidations—PTGS1—malignant glioma	0.000411	0.00172	CbGpPWpGaD
Alprazolam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—malignant glioma	0.000405	0.0017	CbGpPWpGaD
Alprazolam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—malignant glioma	0.000403	0.00169	CbGpPWpGaD
Alprazolam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—malignant glioma	0.000395	0.00166	CbGpPWpGaD
Alprazolam—CYP3A4—Tryptophan metabolism—CAT—malignant glioma	0.000395	0.00165	CbGpPWpGaD
Alprazolam—GABRA1—Neuronal System—BCHE—malignant glioma	0.00039	0.00163	CbGpPWpGaD
Alprazolam—GABRA1—SIDS Susceptibility Pathways—HIF1A—malignant glioma	0.000383	0.0016	CbGpPWpGaD
Alprazolam—CYP2C9—Biological oxidations—CYP2C18—malignant glioma	0.000382	0.0016	CbGpPWpGaD
Alprazolam—CYP2C9—Metapathway biotransformation—CYP2C18—malignant glioma	0.000377	0.00158	CbGpPWpGaD
Alprazolam—GABRA1—Neuronal System—SLC6A3—malignant glioma	0.000367	0.00154	CbGpPWpGaD
Alprazolam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—malignant glioma	0.000362	0.00152	CbGpPWpGaD
Alprazolam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—malignant glioma	0.000361	0.00151	CbGpPWpGaD
Alprazolam—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.000359	0.0015	CbGpPWpGaD
Alprazolam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—malignant glioma	0.000352	0.00147	CbGpPWpGaD
Alprazolam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—malignant glioma	0.000351	0.00147	CbGpPWpGaD
Alprazolam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—malignant glioma	0.000346	0.00145	CbGpPWpGaD
Alprazolam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—malignant glioma	0.000346	0.00145	CbGpPWpGaD
Alprazolam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—malignant glioma	0.000344	0.00144	CbGpPWpGaD
Alprazolam—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	0.00034	0.00142	CbGpPWpGaD
Alprazolam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—malignant glioma	0.00034	0.00142	CbGpPWpGaD
Alprazolam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—malignant glioma	0.000338	0.00142	CbGpPWpGaD
Alprazolam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—malignant glioma	0.000337	0.00141	CbGpPWpGaD
Alprazolam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—malignant glioma	0.000336	0.00141	CbGpPWpGaD
Alprazolam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—malignant glioma	0.000331	0.00139	CbGpPWpGaD
Alprazolam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—malignant glioma	0.00033	0.00138	CbGpPWpGaD
Alprazolam—GABRB3—BDNF signaling pathway—RAF1—malignant glioma	0.000329	0.00138	CbGpPWpGaD
Alprazolam—GABRB2—Transmission across Chemical Synapses—BRAF—malignant glioma	0.000325	0.00136	CbGpPWpGaD
Alprazolam—GABRB2—Ion channel transport—RAF1—malignant glioma	0.000321	0.00134	CbGpPWpGaD
Alprazolam—GABRA5—Transmission across Chemical Synapses—BRAF—malignant glioma	0.000316	0.00132	CbGpPWpGaD
Alprazolam—GABRA5—Ion channel transport—RAF1—malignant glioma	0.000312	0.00131	CbGpPWpGaD
Alprazolam—GABRA3—Transmission across Chemical Synapses—BRAF—malignant glioma	0.00031	0.0013	CbGpPWpGaD
Alprazolam—CYP2C9—Biological oxidations—GSTT1—malignant glioma	0.000309	0.00129	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—RTEL1—malignant glioma	0.000307	0.00129	CbGpPWpGaD
Alprazolam—GABRA3—Ion channel transport—RAF1—malignant glioma	0.000306	0.00128	CbGpPWpGaD
Alprazolam—GABRA2—Transmission across Chemical Synapses—BRAF—malignant glioma	0.000305	0.00128	CbGpPWpGaD
Alprazolam—CYP3A5—Biological oxidations—GSTP1—malignant glioma	0.000304	0.00127	CbGpPWpGaD
Alprazolam—GABRB3—Transmission across Chemical Synapses—BRAF—malignant glioma	0.000303	0.00127	CbGpPWpGaD
Alprazolam—GABRA2—Ion channel transport—RAF1—malignant glioma	0.000301	0.00126	CbGpPWpGaD
Alprazolam—CYP3A5—Metapathway biotransformation—GSTP1—malignant glioma	0.0003	0.00125	CbGpPWpGaD
Alprazolam—GABRB3—Ion channel transport—RAF1—malignant glioma	0.000299	0.00125	CbGpPWpGaD
Alprazolam—CYP2C9—Arachidonic acid metabolism—PTGS2—malignant glioma	0.000298	0.00125	CbGpPWpGaD
Alprazolam—GABRG2—Transmission across Chemical Synapses—BRAF—malignant glioma	0.000297	0.00124	CbGpPWpGaD
Alprazolam—GABRB3—BDNF signaling pathway—CASP3—malignant glioma	0.000295	0.00124	CbGpPWpGaD
Alprazolam—GABRG2—Ion channel transport—RAF1—malignant glioma	0.000294	0.00123	CbGpPWpGaD
Alprazolam—CYP3A4—Biological oxidations—CYP2B6—malignant glioma	0.000291	0.00122	CbGpPWpGaD
Alprazolam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—malignant glioma	0.00029	0.00121	CbGpPWpGaD
Alprazolam—CYP2C9—Biological oxidations—PTGS1—malignant glioma	0.00029	0.00121	CbGpPWpGaD
Alprazolam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—malignant glioma	0.000289	0.00121	CbGpPWpGaD
Alprazolam—CYP3A4—Metapathway biotransformation—CYP2B6—malignant glioma	0.000287	0.0012	CbGpPWpGaD
Alprazolam—GABRB2—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000282	0.00118	CbGpPWpGaD
Alprazolam—GABRA5—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000274	0.00115	CbGpPWpGaD
Alprazolam—GABRB2—Transmission across Chemical Synapses—MDM2—malignant glioma	0.000272	0.00114	CbGpPWpGaD
Alprazolam—GABRB2—Transmission across Chemical Synapses—RAF1—malignant glioma	0.000271	0.00114	CbGpPWpGaD
Alprazolam—GABRA3—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000269	0.00113	CbGpPWpGaD
Alprazolam—GABRA2—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000265	0.00111	CbGpPWpGaD
Alprazolam—GABRA5—Transmission across Chemical Synapses—MDM2—malignant glioma	0.000265	0.00111	CbGpPWpGaD
Alprazolam—GABRA5—Transmission across Chemical Synapses—RAF1—malignant glioma	0.000264	0.0011	CbGpPWpGaD
Alprazolam—GABRB3—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000263	0.0011	CbGpPWpGaD
Alprazolam—GABRA1—Transmission across Chemical Synapses—BRAF—malignant glioma	0.00026	0.00109	CbGpPWpGaD
Alprazolam—GABRA3—Transmission across Chemical Synapses—MDM2—malignant glioma	0.00026	0.00109	CbGpPWpGaD
Alprazolam—GABRB2—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000259	0.00108	CbGpPWpGaD
Alprazolam—GABRA3—Transmission across Chemical Synapses—RAF1—malignant glioma	0.000259	0.00108	CbGpPWpGaD
Alprazolam—GABRG2—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000258	0.00108	CbGpPWpGaD
Alprazolam—GABRA1—Ion channel transport—RAF1—malignant glioma	0.000257	0.00108	CbGpPWpGaD
Alprazolam—GABRA2—Transmission across Chemical Synapses—MDM2—malignant glioma	0.000255	0.00107	CbGpPWpGaD
Alprazolam—GABRA2—Transmission across Chemical Synapses—RAF1—malignant glioma	0.000254	0.00107	CbGpPWpGaD
Alprazolam—GABRB3—Transmission across Chemical Synapses—MDM2—malignant glioma	0.000254	0.00106	CbGpPWpGaD
Alprazolam—GABRB3—Transmission across Chemical Synapses—RAF1—malignant glioma	0.000253	0.00106	CbGpPWpGaD
Alprazolam—CYP3A4—Biological oxidations—CYP2C18—malignant glioma	0.000252	0.00105	CbGpPWpGaD
Alprazolam—GABRA5—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000252	0.00105	CbGpPWpGaD
Alprazolam—GABRG2—Transmission across Chemical Synapses—MDM2—malignant glioma	0.000249	0.00104	CbGpPWpGaD
Alprazolam—GABRB2—Neuronal System—BRAF—malignant glioma	0.000249	0.00104	CbGpPWpGaD
Alprazolam—CYP3A4—Metapathway biotransformation—CYP2C18—malignant glioma	0.000249	0.00104	CbGpPWpGaD
Alprazolam—GABRA1—SIDS Susceptibility Pathways—CXCL8—malignant glioma	0.000248	0.00104	CbGpPWpGaD
Alprazolam—GABRG2—Transmission across Chemical Synapses—RAF1—malignant glioma	0.000248	0.00104	CbGpPWpGaD
Alprazolam—GABRB3—BDNF signaling pathway—STAT3—malignant glioma	0.000248	0.00104	CbGpPWpGaD
Alprazolam—GABRA3—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000247	0.00104	CbGpPWpGaD
Alprazolam—GABRB2—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000247	0.00103	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—COX8A—malignant glioma	0.000244	0.00102	CbGpPWpGaD
Alprazolam—GABRA2—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000243	0.00102	CbGpPWpGaD
Alprazolam—GABRA5—Neuronal System—BRAF—malignant glioma	0.000242	0.00101	CbGpPWpGaD
Alprazolam—GABRB3—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000241	0.00101	CbGpPWpGaD
Alprazolam—GABRA5—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.00024	0.001	CbGpPWpGaD
Alprazolam—GABRA1—SIDS Susceptibility Pathways—IL1B—malignant glioma	0.000238	0.000997	CbGpPWpGaD
Alprazolam—GABRA1—SIDS Susceptibility Pathways—CASP3—malignant glioma	0.000238	0.000995	CbGpPWpGaD
Alprazolam—GABRA3—Neuronal System—BRAF—malignant glioma	0.000238	0.000995	CbGpPWpGaD
Alprazolam—GABRG2—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000237	0.000992	CbGpPWpGaD
Alprazolam—GABRA3—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000235	0.000985	CbGpPWpGaD
Alprazolam—GABRA2—Neuronal System—BRAF—malignant glioma	0.000233	0.000977	CbGpPWpGaD
Alprazolam—GABRB3—Neuronal System—BRAF—malignant glioma	0.000232	0.000971	CbGpPWpGaD
Alprazolam—GABRA2—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000231	0.000968	CbGpPWpGaD
Alprazolam—GABRB3—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.00023	0.000962	CbGpPWpGaD
Alprazolam—GABRG2—Neuronal System—BRAF—malignant glioma	0.000228	0.000954	CbGpPWpGaD
Alprazolam—GABRA1—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000226	0.000945	CbGpPWpGaD
Alprazolam—GABRG2—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000226	0.000945	CbGpPWpGaD
Alprazolam—CYP3A4—Tryptophan metabolism—MDM2—malignant glioma	0.000218	0.000913	CbGpPWpGaD
Alprazolam—GABRA1—Transmission across Chemical Synapses—MDM2—malignant glioma	0.000218	0.000911	CbGpPWpGaD
Alprazolam—GABRA1—Transmission across Chemical Synapses—RAF1—malignant glioma	0.000217	0.000908	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—RTEL1—malignant glioma	0.000217	0.000907	CbGpPWpGaD
Alprazolam—CYP2C9—Biological oxidations—GSTP1—malignant glioma	0.000214	0.000897	CbGpPWpGaD
Alprazolam—CYP2C9—Metapathway biotransformation—GSTP1—malignant glioma	0.000211	0.000884	CbGpPWpGaD
Alprazolam—GABRB2—Neuronal System—MDM2—malignant glioma	0.000209	0.000874	CbGpPWpGaD
Alprazolam—GABRB2—Neuronal System—RAF1—malignant glioma	0.000208	0.000871	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—ASMT—malignant glioma	0.000208	0.000869	CbGpPWpGaD
Alprazolam—GABRA1—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000207	0.000867	CbGpPWpGaD
Alprazolam—CYP3A4—Biological oxidations—GSTT1—malignant glioma	0.000204	0.000853	CbGpPWpGaD
Alprazolam—GABRA5—Neuronal System—MDM2—malignant glioma	0.000203	0.000849	CbGpPWpGaD
Alprazolam—GABRA5—Neuronal System—RAF1—malignant glioma	0.000202	0.000846	CbGpPWpGaD
Alprazolam—GABRA1—SIDS Susceptibility Pathways—VEGFA—malignant glioma	0.000202	0.000844	CbGpPWpGaD
Alprazolam—GABRA1—Neuronal System—BRAF—malignant glioma	0.000199	0.000833	CbGpPWpGaD
Alprazolam—GABRA3—Neuronal System—MDM2—malignant glioma	0.000199	0.000833	CbGpPWpGaD
Alprazolam—GABRA3—Neuronal System—RAF1—malignant glioma	0.000198	0.00083	CbGpPWpGaD
Alprazolam—GABRA1—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000197	0.000826	CbGpPWpGaD
Alprazolam—GABRA2—Neuronal System—MDM2—malignant glioma	0.000196	0.000819	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—BCAN—malignant glioma	0.000195	0.000817	CbGpPWpGaD
Alprazolam—GABRA2—Neuronal System—RAF1—malignant glioma	0.000195	0.000816	CbGpPWpGaD
Alprazolam—GABRB3—Neuronal System—MDM2—malignant glioma	0.000194	0.000814	CbGpPWpGaD
Alprazolam—GABRB3—Neuronal System—RAF1—malignant glioma	0.000194	0.000811	CbGpPWpGaD
Alprazolam—CYP3A4—Biological oxidations—PTGS1—malignant glioma	0.000191	0.000799	CbGpPWpGaD
Alprazolam—GABRG2—Neuronal System—MDM2—malignant glioma	0.000191	0.000799	CbGpPWpGaD
Alprazolam—GABRG2—Neuronal System—RAF1—malignant glioma	0.00019	0.000796	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—COX8A—malignant glioma	0.000176	0.000739	CbGpPWpGaD
Alprazolam—GABRA1—SIDS Susceptibility Pathways—TNF—malignant glioma	0.000173	0.000724	CbGpPWpGaD
Alprazolam—GABRA1—Neuronal System—MDM2—malignant glioma	0.000167	0.000698	CbGpPWpGaD
Alprazolam—GABRA1—Neuronal System—RAF1—malignant glioma	0.000166	0.000696	CbGpPWpGaD
Alprazolam—GABRB3—BDNF signaling pathway—AKT1—malignant glioma	0.00016	0.000669	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—IDH2—malignant glioma	0.000157	0.000658	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	0.000155	0.000648	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—ASMT—malignant glioma	0.00015	0.000628	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	0.00015	0.000627	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—CYP2B6—malignant glioma	0.000148	0.000619	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—RTEL1—malignant glioma	0.000143	0.000598	CbGpPWpGaD
Alprazolam—CYP3A4—Biological oxidations—GSTP1—malignant glioma	0.000141	0.000591	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—BCAN—malignant glioma	0.000141	0.00059	CbGpPWpGaD
Alprazolam—CYP3A4—Metapathway biotransformation—GSTP1—malignant glioma	0.000139	0.000583	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—IDH1—malignant glioma	0.000135	0.000566	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—SPHK1—malignant glioma	0.000131	0.000548	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—CYP2C18—malignant glioma	0.000128	0.000537	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—COX8A—malignant glioma	0.000124	0.000521	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—IDH2—malignant glioma	0.000114	0.000476	CbGpPWpGaD
Alprazolam—GABRB2—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000112	0.000468	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	0.000111	0.000465	CbGpPWpGaD
Alprazolam—GABRA5—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000109	0.000455	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—CYP2B6—malignant glioma	0.000107	0.000448	CbGpPWpGaD
Alprazolam—GABRA3—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000107	0.000446	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—ASMT—malignant glioma	0.000106	0.000443	CbGpPWpGaD
Alprazolam—GABRA2—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000105	0.000439	CbGpPWpGaD
Alprazolam—GABRB3—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000104	0.000436	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—GSTT1—malignant glioma	0.000104	0.000434	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	0.000103	0.000433	CbGpPWpGaD
Alprazolam—GABRG2—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000102	0.000428	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—BCAN—malignant glioma	9.94e-05	0.000416	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—IDH1—malignant glioma	9.78e-05	0.000409	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—PTGS1—malignant glioma	9.72e-05	0.000407	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—SPHK1—malignant glioma	9.46e-05	0.000396	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—CYP2C18—malignant glioma	9.27e-05	0.000388	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—BCHE—malignant glioma	9.03e-05	0.000378	CbGpPWpGaD
Alprazolam—GABRA1—Transmembrane transport of small molecules—RAF1—malignant glioma	8.94e-05	0.000374	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—SLC5A5—malignant glioma	8.92e-05	0.000374	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—COX8A—malignant glioma	8.2e-05	0.000343	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—IDH2—malignant glioma	8.01e-05	0.000336	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	7.56e-05	0.000316	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—CYP2B6—malignant glioma	7.54e-05	0.000315	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—GSTT1—malignant glioma	7.5e-05	0.000314	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—GSTP1—malignant glioma	7.19e-05	0.000301	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—PTGS1—malignant glioma	7.02e-05	0.000294	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—CAT—malignant glioma	6.99e-05	0.000293	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—ASMT—malignant glioma	6.97e-05	0.000292	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—IDH1—malignant glioma	6.89e-05	0.000289	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—SPHK1—malignant glioma	6.67e-05	0.000279	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—NCOR1—malignant glioma	6.61e-05	0.000277	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—BCAN—malignant glioma	6.56e-05	0.000275	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—CYP2C18—malignant glioma	6.53e-05	0.000274	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—BCHE—malignant glioma	6.53e-05	0.000273	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—SLC5A5—malignant glioma	6.45e-05	0.00027	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	6.16e-05	0.000258	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	5.61e-05	0.000235	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	5.42e-05	0.000227	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—CAV1—malignant glioma	5.38e-05	0.000225	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—IDH2—malignant glioma	5.29e-05	0.000221	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—GSTT1—malignant glioma	5.28e-05	0.000221	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—GSTP1—malignant glioma	5.2e-05	0.000218	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—CAT—malignant glioma	5.06e-05	0.000212	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—CYP2B6—malignant glioma	4.97e-05	0.000208	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—PTGS1—malignant glioma	4.95e-05	0.000207	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	4.93e-05	0.000207	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—PIK3CG—malignant glioma	4.9e-05	0.000205	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—NCOR1—malignant glioma	4.77e-05	0.0002	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—PPARG—malignant glioma	4.73e-05	0.000198	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—BCHE—malignant glioma	4.6e-05	0.000193	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—SLC5A5—malignant glioma	4.55e-05	0.00019	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—IDH1—malignant glioma	4.55e-05	0.00019	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—SPHK1—malignant glioma	4.4e-05	0.000184	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—PIK3CD—malignant glioma	4.31e-05	0.000181	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—CYP2C18—malignant glioma	4.31e-05	0.00018	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	4.3e-05	0.00018	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	4.26e-05	0.000178	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—CAV1—malignant glioma	3.89e-05	0.000163	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—PIK3CB—malignant glioma	3.76e-05	0.000157	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—PTGS2—malignant glioma	3.72e-05	0.000156	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	3.72e-05	0.000156	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—GSTP1—malignant glioma	3.66e-05	0.000153	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—CAT—malignant glioma	3.56e-05	0.000149	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—PIK3CG—malignant glioma	3.55e-05	0.000148	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—GSTT1—malignant glioma	3.48e-05	0.000146	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—PPARG—malignant glioma	3.42e-05	0.000143	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—NCOR1—malignant glioma	3.37e-05	0.000141	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—PTGS1—malignant glioma	3.27e-05	0.000137	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—PTEN—malignant glioma	3.25e-05	0.000136	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—PIK3CD—malignant glioma	3.12e-05	0.00013	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—BCHE—malignant glioma	3.04e-05	0.000127	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—SLC5A5—malignant glioma	3e-05	0.000126	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—CAV1—malignant glioma	2.74e-05	0.000115	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—PIK3CB—malignant glioma	2.72e-05	0.000114	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—PTGS2—malignant glioma	2.69e-05	0.000113	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	2.62e-05	0.00011	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—PIK3CG—malignant glioma	2.5e-05	0.000105	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—GSTP1—malignant glioma	2.42e-05	0.000101	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—PPARG—malignant glioma	2.41e-05	0.000101	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—CAT—malignant glioma	2.35e-05	9.84e-05	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—PTEN—malignant glioma	2.35e-05	9.83e-05	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—PIK3CA—malignant glioma	2.29e-05	9.59e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—NCOR1—malignant glioma	2.22e-05	9.29e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—PIK3CD—malignant glioma	2.2e-05	9.2e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—PIK3CB—malignant glioma	1.92e-05	8.02e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—PTGS2—malignant glioma	1.9e-05	7.94e-05	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—AKT1—malignant glioma	1.87e-05	7.83e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—CAV1—malignant glioma	1.81e-05	7.58e-05	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—PIK3CA—malignant glioma	1.66e-05	6.93e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—PTEN—malignant glioma	1.65e-05	6.93e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—PIK3CG—malignant glioma	1.65e-05	6.9e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—PPARG—malignant glioma	1.59e-05	6.66e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—PIK3CD—malignant glioma	1.45e-05	6.07e-05	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—AKT1—malignant glioma	1.35e-05	5.66e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—PIK3CB—malignant glioma	1.26e-05	5.29e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—PTGS2—malignant glioma	1.25e-05	5.24e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—PIK3CA—malignant glioma	1.17e-05	4.89e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—PTEN—malignant glioma	1.09e-05	4.57e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—AKT1—malignant glioma	9.54e-06	3.99e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—PIK3CA—malignant glioma	7.7e-06	3.22e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—AKT1—malignant glioma	6.29e-06	2.63e-05	CbGpPWpGaD
